Emory Proton Therapy Center Breaks Ground Atlanta

June 24, 2013 — A new first for Georgia was celebrated Thursday, May 2, as Emory Healthcare and the Winship Cancer Institute broke ground on the new Emory Proton Therapy Center. Brasfield & Gorrie, the general contractor on the more than $200 million dollar oncology center, was joined in the celebration by developer Advanced Particle Therapy and elected officials, including Atlanta Mayor Kasim Reed.

In his remarks, Mayor Reed addressed the center’s impact, not only on the lives of patients but also on the city’s economic and research development.

Located in downtown Atlanta at the corner of Peachtree Street and North Avenue, the 107,000 square foot center will accommodate approximately 2,200 cancer patients each year. The facility will open its doors to patients in 2016 after an 18-month commissioning period for the Varian Medical Systems equipment.

The new proton treatment facility will incorporate several unique features, including the 16-foot-thickspecialized shielding walls necessary to house pencil beam scanning equipment. To date, only one proton therapy center in the nation offers pencil beam scanning capabilities and in only one room. The Emory Proton Therapy Center will feature this advanced capability in all five of its treatment rooms.

Under the direction of developer Advanced Particle Therapy, Brasfield & Gorrie is working with Signet Development, Emory Healthcare, VOA Associates and Perkins+Will.

“This facility represents a wonderful opportunity to fulfill a health care need for the people of Georgia and surrounding states. We look forward to a successful building process and turning over a treatment center that will improve the lives of many patients,” said Trey Sanders, regional president of Brasfield & Gorrie.

For more information: www.brasfieldgorrie.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now